Subunit Rotavirus Vaccines and Mucosal Immunity

亚单位轮状病毒疫苗和粘膜免疫

• 批准号: 6845654
• 负责人: Margaret E. Conner
• 金额: $ 38.75万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-07-01 至 2008-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6845654
• 关键词: B lymphocyte; Rotavirus; antibody formation; cell migration; cytokine; helper T lymphocyte; immunoglobulin A; immunoglobulin G; immunoglobulin M; interferon gamma; interleukin 10; interleukin 12; interleukin 4; interleukin 5; interleukin 6; laboratory mouse; leukocyte activation /transformation; microorganism immunology; mucosal immunity; protein biosynthesis; rotavirus vaccines; transforming growth factors; tumor necrosis factor alpha; vaccine development; viruslike particle

Although 80% of infectious diseases are initiated at mucosal surfaces, our knowledge of the mechanisms of induction and regulation of mucosal immunity and our ability to exploit the mucosal immune system to prevent infections at or across mucosal surfaces is limited. We have proposed a novel model for regulation of intestinal immunity to enteric viruses by TH1 and TH3, but not TH2 cytokines. We propose that TGF- beta (TH3) regulates the antigen-specific IgA response. Studies proposed in this renewal grant application seek to determine the validity of our model. Rotavirus and VLPs will be used to probe the responses to infection or immunization to define the mechanisms and molecules necessary to induce protective intestinal immune responses. It is hypothesized that VLPs and live rotavirus induce protective immunity by different mechanisms since they induce different IgG subclasses and widely divergent IgA responses. It is further hypothesized that VLPs administered intranasally can overcome the compartmentalized immune responses reported to occur in the common mucosal immune system. The specific aims are to determine how differences in protective efficacy of virus and VLPs are regulated by differences in (1) inductive or effector cytokine responses, (2) B cell responses, or (3) homing of memory lymphocytes. Quantitative analysis of the B cell responses and cytokine profiles induced following a variety of mucosal immunization protocols and virus challenge will be performed in normal, specifically-- depleted, -upregulated or knockout mice. The results from these basic studies will be relevant to understanding immune regulation and functions at mucosal surfaces and may confirm a novel regulatory mechanism. Further, they will facilitate the design of more effective vaccines for rotavirus and other enteric viruses. The knowledge gained from these basic studies also will be useful in development of new effective vaccine strategies for viral pathogens such as HIV that infect at or invade across mucosal surfaces.

虽然80%的传染病起源于粘膜表面，但我们对粘膜免疫的诱导和调节机制的了解以及利用粘膜免疫系统预防粘膜表面或跨粘膜表面感染的能力有限。我们提出了一个新的模型，通过TH1和TH3而不是TH2细胞因子调节肠道对肠道病毒的免疫。我们提出TGF- β (TH3)调节抗原特异性IgA反应。本续期拨款申请中提出的研究旨在确定我们模型的有效性。轮状病毒和VLPs将用于探测感染或免疫反应，以确定诱导保护性肠道免疫反应所需的机制和分子。假设VLPs和活轮状病毒诱导保护性免疫的机制不同，因为它们诱导不同的IgG亚类和广泛不同的IgA反应。进一步的假设是，经鼻给药的VLPs可以克服在普通粘膜免疫系统中发生的区隔免疫反应。具体目的是确定病毒和VLPs的保护功效差异如何受到以下方面的差异的调节：(1)诱导或效应细胞因子反应，(2)B细胞反应，或(3)记忆淋巴细胞归巢。在正常小鼠、特异性缺失小鼠、特异性上调小鼠和基因敲除小鼠中，定量分析多种粘膜免疫方案和病毒攻击诱导的B细胞反应和细胞因子谱。这些基础研究的结果将有助于理解粘膜表面的免疫调节和功能，并可能证实一种新的调节机制。此外，它们将有助于设计更有效的轮状病毒和其他肠道病毒疫苗。从这些基础研究中获得的知识也将有助于开发新的有效疫苗策略，用于治疗在粘膜表面感染或侵入粘膜表面的艾滋病毒等病毒性病原体。